A pragmatic approach to monitor and evaluate implementation and impact of differentiated ART delivery for global and national stakeholders
- PMID: 29537628
- PMCID: PMC5851343
- DOI: 10.1002/jia2.25080
A pragmatic approach to monitor and evaluate implementation and impact of differentiated ART delivery for global and national stakeholders
Abstract
Introduction: The World Health Organization's (WHO) recommendation of "Treat All" has accelerated the call for differentiated antiretroviral therapy (ART) delivery, a method of care that efficiently uses limited resources to increase access to HIV treatment. WHO has further recommended that stable individuals on ART receive refills every 3 to 6 months and attend clinical visits every 3 to 6 months. However, there is not yet consensus on how to ensure that the quality of services is maintained as countries strive to meet these standards. This commentary responds to this gap by defining a pragmatic approach to the monitoring and evaluation (M&E) of the scale up of differentiated ART delivery for global and national stakeholders.
Discussion: Programme managers need to demonstrate that the scale up of differentiated ART delivery is achieving the desired effectiveness and efficiency outcomes to justify continued support by national and global stakeholders. To achieve this goal, the two existing global WHO HIV treatment indicators of ART retention and viral suppression should be augmented with two broad aggregate measures. The addition of indicators measuring the frequency of (1) clinical and (2) refill visits by PLHIV per year will allow evaluation of the pace of scale up while monitoring its overall effect on the quality and efficiency of services. The combination of these four routinely collected aggregate indicators will also facilitate the comparison of outcomes among facilities, regions or countries implementing different models of ART delivery. Enhanced monitoring or additional assessments will be required to answer other critical questions on the process of implementation, acceptability, effectiveness and efficiency.
Conclusions: These proposed outcomes are useful markers for the effectiveness and efficiency of the health system's attempts to deliver quality treatment to those who need it-and still reserve as much of the available resource pool as possible for other key elements of the HIV response.
Keywords: HIV; differentiated care; differentiated service delivery; efficiency; health care worker experience; monitoring and evaluation; patient experience; productivity.
© 2018 The Authors. Journal of the International AIDS Society published by John Wiley & sons Ltd on behalf of the International AIDS Society.
References
-
- World Health Organization . Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach –. 2nd ed Geneva, Switzerland: WHO; 2016. - PubMed
-
- UNAIDS . Ending AIDS: Progress towards 90‐90‐90 targets. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS) 2017.
-
- World Health Organization, International AIDS Society (IAS), CDC, USAID, PEPFAR . Key Considerations for differentiated service delivery for specific populations: Children, adolescents, pregnant and breastfeeding women and key populations. Geneva: World Health Organization 2017.
-
- Ministry of Health and Child Care . Operational and service delivery manual for prevention, care and treatment of HIV in Zimbabwe In: Programme AT, editor. Zimbabwe: Ministry of Health and Child Care; 2017.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
